Epigenetics Market
According to Intent Market Research, the Epigenetics Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 24.0% to touch USD 4.2 billion by 2030. The Epigenetics Market is dominated by key players such as Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Merck KGaA, Darmstadt, Germany, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Abcam plc, PerkinElmer, Inc., Zymo Research Corporation, Active Motif, Inc., EpigenDx, Inc., Cambridge Epigenetix Ltd., System Biosciences, Becton, Dickinson and Company.